查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513244

2024 年核糖核酸 (RNA)定序全球市场报告

Ribonucleic Acid (RNA) Sequencing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

核糖核酸 (RNA)定序的市场规模预计在未来几年将大幅成长。到 2028 年，这一数字将以 22.4% 的年复合成长率（CAGR）增长至 72.9 亿美元。展望预测期内，对快速准确疾病诊断的需求不断增加、实时聚合酵素链锁反应技术的广泛使用、对快速现场诊断测试的需求不断增加、感染疾病爆发不断增加以及需求增加将推动增长预计用于伴同性诊断。这段时期预计的主要趋势包括疾病检测和监测、药物发现过程、目标检验技术、生物标记识别方法、DNA定序技术、诊断测试方法的增强、下一代定序（NGS）的出现，其中包括整合微流体、实验室晶片平台以及先进分子诊断解决方案的开发。

核糖核酸（RNA）定序市场的成长轨迹预计将受到对精准医疗的日益关注的推动。精准医学，也称为个人化医疗，是一种考虑基因、环境和生活方式的个体差异的创新治疗和预防方法。在基因组学进步、疾病复杂性增加和支持性监管措施的推动下，这种方法有望提供更有效的治疗方法。 RNA序列测定技术在这种情况下发挥重要作用，它可以对样品内的 RNA 分子序列测定并量化表现量。此类技术有助于对转录组进行全面分析，深入了解基因表现模式、选择性剪接事件和 RNA 修饰。值得注意的是，FDA 于 2024 年 2 月核准了针对罕见疾病患者的 16 种新的个人化治疗方法。因此，对精准医疗的日益关注正在推动核糖核酸 (RNA)定序市场的扩张。

在核糖核酸 (RNA)定序市场中，主要企业正在优先考虑 RNA 下一代定序分析，透过资料主导的见解和精准医疗来增强患者照护。 RNA 新一代定序分析利用先进的基因组定序技术来分析患者的整个EXOME并代表下一代EXOME定序平台。例如，2023年6月，美国精准医疗科技公司Tempus宣布推出一款新的独立RNA次世代定序试剂盒Tempus xR。这种创新检测方法专为固体癌定制，可对整个转录组进行全面分析，识别 100 多个目标基因的临床重要融合以及 MET 外显子 14 和 EGFRvIII 的剪接。此检测适用于对 RNA 融合和剪接变化有特殊兴趣的医生，以及寻求对现有样本进行详细 RNA 序列分析的医疗保健提供者、研究人员和生物製药公司。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球核糖核酸 (RNA)定序市场：驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球核糖核酸 (RNA)定序市场表现：规模与成长，2018-2023 年
  • 全球核糖核酸 (RNA)定序市场预测：规模与成长，2023-2028 年，2033F

第六章 市场细分

  • 全球核糖核酸 (RNA)定序市场：按产品类型分類的表现和预测，2018-2023、2023-2028F、2033F
  • 装置
  • 试剂和套件
  • 软体
  • 全球核糖核酸 (RNA)定序市场：依技术分類的表现与预测，2018-2023、2023-2028F、2033F
  • 基于单分子的定序
  • 定序合成技术
  • 奈米孔定序技术
  • 离子激流半导体定序
  • 全球核糖核酸 (RNA)定序市场：按应用分類的表现和预测，2018-2023、2023-2028F、2033F
  • 诊断
  • 药物发现
  • 转换医学
  • 其他用途
  • 全球核糖核酸 (RNA)定序市场：最终用户的实际情况和预测，2018-2023、2023-2028F、2033F
  • 研究和学术
  • 医院和诊所
  • 製药和生物技术公司
  • 其他最终用户

第 7 章 区域/国家分析

  • 全球核糖核酸 (RNA)定序市场：按地区分類的表现和预测，2018-2023、2023-2028F、2033F
  • 全球核糖核酸 (RNA)定序市场：按国家、表现和预测，2018-2023、2023-2028F、2033F

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 核糖核酸（RNA）定序市场：竞争格局
  • 核糖核酸 (RNA)定序市场：公司简介
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • Becton, Dickinson and Company

第31章 其他大型创新企业

  • GE HealthCare Technologies Inc
  • Eurofins Scientific SE
  • Agilent Technologies Inc
  • Illumina Inc
  • PerkinElmer Inc
  • bioMerieux SA
  • Beckman Coulter Inc
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc
  • QIAGEN NV
  • Tecan Genomics Inc
  • Natera Inc
  • Myriad Genetics Inc.
  • BGI Genomics Co Ltd
  • Takara Bio Inc

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章前瞻性与潜力分析

第36章附录

简介目录
Product Code: r18231

RNA sequencing, employing next-generation sequencing techniques, unveils the presence and abundance of RNA molecules within a biological specimen, offering a glimpse into gene expression dynamics. This methodology empowers scientists to delve into gene expression patterns, unearth novel transcripts, and decipher RNA processing mechanisms.

Within the realm of ribonucleic acid (RNA) sequencing, the primary product categories comprise instruments, reagents and kits, and software. Instruments encompass the tangible apparatuses utilized for RNA molecule analysis, encompassing sequencers and polymerase chain reaction devices, pivotal for accurate RNA sample processing and examination. Diverse technologies, including single molecule-based sequencing, sequence by synthesis, nanopore sequencing, and ion torrent semiconductor sequencing, find application across various sectors such as diagnostics, drug discovery, and translational medicine. End-users span research and academia, hospitals and clinics, pharmaceutical and biotechnology firms, among others.

The ribonucleic acid (RNA) sequencing market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid (RNA) sequencing market statistics, including ribonucleic acid (RNA) sequencing industry global market size, regional shares, competitors with a ribonucleic acid (RNA) sequencing market share, detailed ribonucleic acid (RNA) sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (RNA) sequencing industry. This ribonucleic acid (RNA) sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ribonucleic acid (RNA) sequencing market size has grown exponentially in recent years. It will grow from $2.66 billion in 2023 to $7.29 billion in 2024 at a compound annual growth rate (CAGR) of 22.2%. In the historical period, growth stemmed from several factors, including an upsurge in drug development endeavors, an expanding prevalence of genetic disorders and target diseases, a surge in the utilization of compact portable instruments, an increasing focus on biomarker profiling, a mounting demand for personalized medicine, and a rising population of cancer patients.

The ribonucleic acid (RNA) sequencing market size is expected to see exponential growth in the next few years. It will grow to $7.29 billion in 2028 at a compound annual growth rate (CAGR) of 22.4%. Looking ahead to the forecast period, growth is anticipated due to heightened demand for swift and precise disease diagnosis, widespread adoption of real-time polymerase chain reaction techniques, increasing need for rapid and on-site diagnostic tests, escalation in infectious disease outbreaks, and the demand for companion diagnostics. Significant trends expected during this period encompass advancements in disease detection and monitoring, drug discovery processes, target validation techniques, biomarker identification methods, DNA sequencing technologies, enhancements in diagnostic testing methodologies, the emergence of next-generation sequencing (NGS), the integration of microfluidics, lab-on-a-chip platforms, and the development of advanced molecular diagnostic solutions.

The growth trajectory of the ribonucleic acid (RNA) sequencing market is expected to be propelled by an increasing emphasis on precision medicine. Precision medicine, also known as personalized medicine, represents an innovative approach to medical treatment and prevention, taking into account individual variability in genes, environment, and lifestyle. This approach holds promise for offering more effective treatments, spurred by advancements in genomics, the rising complexity of diseases, and supportive regulatory measures. RNA sequencing technologies play a crucial role in this landscape, enabling the determination of RNA molecule sequences and quantification of their expression levels within samples. Such technologies facilitate comprehensive analysis of transcriptomes, offering insights into gene expression patterns, alternative splicing events, and RNA modifications. Notably, in February 2024, the FDA approved 16 novel personalized therapies for patients with rare diseases, compared to six approvals in 2022, as reported by the Personalized Medicine Coalition. Consequently, the growing focus on precision medicine serves as a driving force behind the ribonucleic acid (RNA) sequencing market's expansion.

In the ribonucleic acid (RNA) sequencing market, key players prioritize RNA next-generation sequencing assays to enhance patient care through data-driven insights and precision medicine. RNA next-generation sequencing assays leverage advanced genomic sequencing technologies to analyze a patient's entire exome, representing a next-generation exome sequencing platform. For example, in June 2023, Tempus, a US-based precision medicine technology company, introduced its new standalone RNA next-generation sequencing assay, Tempus xR. This innovative assay, tailored for solid tumors, provides a comprehensive analysis of the entire transcriptome, identifying clinically significant fusions in over 100 targeted genes and altered splicing for MET Exon 14 and EGFRvIII. This offering caters to physicians with specific interests in RNA fusions or altered splicing, as well as to providers, researchers, and biopharma companies seeking detailed RNA sequencing analysis for their existing samples.

In January 2024, Parse Biosciences, a US-based biotechnology company focusing on developing innovative solutions for biological research and diagnostics, completed the acquisition of Biomage for an undisclosed sum. This acquisition enables Parse Biosciences to integrate Biomage's robust data analysis tools, including its Cellenics cloud-based platform, into Parse's Evercode combinatorial barcoding technology. Biomage Ltd., based in the UK, specializes in RNA sequencing and analysis software and services.

Major companies operating in the ribonucleic acid (RNA) sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE HealthCare Technologies Inc, Eurofins Scientific SE, Agilent Technologies Inc, Illumina Inc, PerkinElmer Inc, bioMerieux SA, Beckman Coulter Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN N.V., Tecan Genomics Inc, Natera Inc, Myriad Genetics Inc., BGI Genomics Co Ltd, Takara Bio Inc, Cepheid, NeoGenomics Laboratories Inc, Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc, Macrogen Inc, Standard BioTools Inc, Ambry Genetics Corporation, Biocartis SA, CD Genomics.

North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ribonucleic acid (RNA) sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ribonucleic acid (RNA) sequencing market consists of revenues earned by entities by providing services such as library preparation, RNA extraction, fragmentation, reverse transcription, adapter ligation, sequencing, data analysis, bioinformatics support, consultation and experimental design, quality control, sample preparation services, gene cloning, genotyping and mutation detection, and pathogen detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The ribonucleic acid (RNA) sequencing market also includes sales of library preparation kits, RNA extraction kits, quantification kits, polymerase chain reaction (PCR) instruments, pipette tips, tubes, and plates. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ribonucleic Acid (RNA) Sequencing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ribonucleic acid (RNA) sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ribonucleic acid (RNA) sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ribonucleic acid (RNA) sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Instruments; Reagents And Kits; Software
  • 2) By Technology: Single Molecule Based Sequencing; Sequence By Synthesis Technology; Nanopore Sequencing Technology; Ion Torrent Semiconductor Sequencing
  • 3) By Applications: Diagnostics; Drug Discovery; Translational Medicine; Other Applications
  • 4) By End User: Research And Academia; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Becton, Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ribonucleic Acid (RNA) Sequencing Market Characteristics

3. Ribonucleic Acid (RNA) Sequencing Market Trends And Strategies

4. Ribonucleic Acid (RNA) Sequencing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Ribonucleic Acid (RNA) Sequencing Market Size and Growth

  • 5.1. Global Ribonucleic Acid (RNA) Sequencing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Ribonucleic Acid (RNA) Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Ribonucleic Acid (RNA) Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Ribonucleic Acid (RNA) Sequencing Market Segmentation

  • 6.1. Global Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Instruments
  • Reagents And Kits
  • Software
  • 6.2. Global Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Single Molecule Based Sequencing
  • Sequence By Synthesis Technology
  • Nanopore Sequencing Technology
  • Ion Torrent Semiconductor Sequencing
  • 6.3. Global Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostics
  • Drug Discovery
  • Translational Medicine
  • Other Applications
  • 6.4. Global Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Research And Academia
  • Hospitals And Clinics
  • Pharmaceutical And Biotechnology Companies
  • Other End Users

7. Ribonucleic Acid (RNA) Sequencing Market Regional And Country Analysis

  • 7.1. Global Ribonucleic Acid (RNA) Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Ribonucleic Acid (RNA) Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Ribonucleic Acid (RNA) Sequencing Market

  • 8.1. Asia-Pacific Ribonucleic Acid (RNA) Sequencing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Ribonucleic Acid (RNA) Sequencing Market

  • 9.1. China Ribonucleic Acid (RNA) Sequencing Market Overview
  • 9.2. China Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Ribonucleic Acid (RNA) Sequencing Market

  • 10.1. India Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Ribonucleic Acid (RNA) Sequencing Market

  • 11.1. Japan Ribonucleic Acid (RNA) Sequencing Market Overview
  • 11.2. Japan Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Ribonucleic Acid (RNA) Sequencing Market

  • 12.1. Australia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Ribonucleic Acid (RNA) Sequencing Market

  • 13.1. Indonesia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Ribonucleic Acid (RNA) Sequencing Market

  • 14.1. South Korea Ribonucleic Acid (RNA) Sequencing Market Overview
  • 14.2. South Korea Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Ribonucleic Acid (RNA) Sequencing Market

  • 15.1. Western Europe Ribonucleic Acid (RNA) Sequencing Market Overview
  • 15.2. Western Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Ribonucleic Acid (RNA) Sequencing Market

  • 16.1. UK Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Ribonucleic Acid (RNA) Sequencing Market

  • 17.1. Germany Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Ribonucleic Acid (RNA) Sequencing Market

  • 18.1. France Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Ribonucleic Acid (RNA) Sequencing Market

  • 19.1. Italy Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Ribonucleic Acid (RNA) Sequencing Market

  • 20.1. Spain Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market

  • 21.1. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market Overview
  • 21.2. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Ribonucleic Acid (RNA) Sequencing Market

  • 22.1. Russia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Ribonucleic Acid (RNA) Sequencing Market

  • 23.1. North America Ribonucleic Acid (RNA) Sequencing Market Overview
  • 23.2. North America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Ribonucleic Acid (RNA) Sequencing Market

  • 24.1. USA Ribonucleic Acid (RNA) Sequencing Market Overview
  • 24.2. USA Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Ribonucleic Acid (RNA) Sequencing Market

  • 25.1. Canada Ribonucleic Acid (RNA) Sequencing Market Overview
  • 25.2. Canada Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Ribonucleic Acid (RNA) Sequencing Market

  • 26.1. South America Ribonucleic Acid (RNA) Sequencing Market Overview
  • 26.2. South America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Ribonucleic Acid (RNA) Sequencing Market

  • 27.1. Brazil Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Ribonucleic Acid (RNA) Sequencing Market

  • 28.1. Middle East Ribonucleic Acid (RNA) Sequencing Market Overview
  • 28.2. Middle East Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Ribonucleic Acid (RNA) Sequencing Market

  • 29.1. Africa Ribonucleic Acid (RNA) Sequencing Market Overview
  • 29.2. Africa Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Ribonucleic Acid (RNA) Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Ribonucleic Acid (RNA) Sequencing Market Competitive Landscape
  • 30.2. Ribonucleic Acid (RNA) Sequencing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Danaher Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck KGaA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Becton, Dickinson and Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Ribonucleic Acid (RNA) Sequencing Market Other Major And Innovative Companies

  • 31.1. GE HealthCare Technologies Inc
  • 31.2. Eurofins Scientific SE
  • 31.3. Agilent Technologies Inc
  • 31.4. Illumina Inc
  • 31.5. PerkinElmer Inc
  • 31.6. bioMerieux SA
  • 31.7. Beckman Coulter Inc
  • 31.8. Sysmex Corporation
  • 31.9. Bio-Rad Laboratories Inc
  • 31.10. QIAGEN N.V.
  • 31.11. Tecan Genomics Inc
  • 31.12. Natera Inc
  • 31.13. Myriad Genetics Inc.
  • 31.14. BGI Genomics Co Ltd
  • 31.15. Takara Bio Inc

32. Global Ribonucleic Acid (RNA) Sequencing Market Competitive Benchmarking

33. Global Ribonucleic Acid (RNA) Sequencing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Ribonucleic Acid (RNA) Sequencing Market

35. Ribonucleic Acid (RNA) Sequencing Market Future Outlook and Potential Analysis

  • 35.1 Ribonucleic Acid (RNA) Sequencing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Ribonucleic Acid (RNA) Sequencing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Ribonucleic Acid (RNA) Sequencing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer